Our model results in Notch1 activation from the endogenous locus, and early studies suggest that the γ-secretase inhibitor DAPT can limit proliferation of R26PR;cre T-ALL; therefore, this model will be useful for future evaluation of therapeutics targeting NOTCH1-driven human T-ALL. This evidence concerns the gene NOTCH1 and acute lymphoblastic leukemia.